Results overview: Found 6 records in 0.02 seconds.
Articles, 5 records found
Research literature, 1 records found
Articles 5 records found  
1.
14 p, 2.2 MB Multiplex RNA-based detection of clinically relevant MET alterations in advanced non-small cell lung cancer / Aguado, Cristina (Quirón Dexeus University Hospital) ; Teixidó, Cristina (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Román, Ruth (Quirón Dexeus University Hospital) ; Reyes, Roxana (Hospital Clínic i Provincial de Barcelona) ; Giménez-Capitán, Ana (Quirón Dexeus University Hospital) ; Marin, Elba (Hospital Clínic i Provincial de Barcelona) ; Cabrera, Carlos (Grup Quirónsalud (Barcelona, Catalunya)) ; Viñolas, Nuria (Hospital Clínic i Provincial de Barcelona) ; Castillo, Sergi (Hospital General de Granollers) ; Muñoz, Silvia (Hospital General de Granollers) ; Arcocha, Ainara (Hospital Clínic i Provincial de Barcelona) ; López Vilaró, Laura (Institut d'Investigació Biomèdica Sant Pau) ; Sullivan, Ivana (Institut d'Investigació Biomèdica Sant Pau) ; Aldeguer, Erika (Quirón Dexeus University Hospital) ; Rodríguez, Sonia (Quirón Dexeus University Hospital) ; Moya, Irene (Grup Quirónsalud (Barcelona, Catalunya)) ; Viteri, Santiago (Quiron Salud Group) ; Cardona Zorrilla, Andrés Felipe (Clínica del Country) ; Palmero, Ramon (L'Hospitalet) ; Sainz, Cristina (Centro de Investigación Biomédica en Red de Cáncer) ; Mesa-Guzmán, Miguel (Universidad Pública de Navarra) ; Lozano, Maria D. (Universidad Pública de Navarra) ; Aguilar-Hernández, Andrés (Grup Quirónsalud (Barcelona, Catalunya)) ; Martínez-Bueno, Alejandro (Grup Quirónsalud (Barcelona, Catalunya)) ; González-Cao, María (Grup Quirónsalud (Barcelona, Catalunya)) ; Gonzalvo, Elena (Hospital Clínic i Provincial de Barcelona) ; Leenders, William P. J. (Radboud Institute for Molecular Life Sciences) ; Rosell, Rafael (Universitat Autònoma de Barcelona. Departament de Medicina) ; Montuenga, Luis M. (Universidad Pública de Navarra) ; Prat, Aleix (Hospital Clínic i Provincial de Barcelona) ; Molina-Vila, Miguel Ángel (Quirón Dexeus University Hospital) ; Reguart, Noemi (Hospital Clínic i Provincial de Barcelona)
We studied MET alterations in 474 advanced non-small-cell lung cancer (NSCLC) patients by nCounter, an RNA-based technique. We identified 3% with MET Δex14 mRNA and 3. 5% with very-high MET mRNA expression, a surrogate of MET amplification. [...]
2020 - 10.1002/1878-0261.12861
Molecular Oncology, Vol. 15 (december 2020) , p. 350-363  
2.
9 p, 774.2 KB Mortality and Advanced Support Requirement for Patients With Cancer With COVID-19 : A Mathematical Dynamic Model for Latin America / Ruiz-Patiño, Alejandro (Molecular Oncology and Biology Systems Research Group. Universidad el Bosque) ; Arrieta, Oscar (Instituto Nacional de Cancerología (Ciutat de Mèxic). Thoracic Oncology Unit) ; Pino, Luis E. (Fundación Santa Fe de Bogotá) ; Rolfo, Christian (Marlene and Stewart Comprehensive Cancer Center. Experimental Therapeutics Program. School of Medicine. University of Maryland) ; Ricaurte, Luisa (Molecular Oncology and Biology Systems Research Group. Universidad el Bosque) ; Recondo, Gonzalo (Center for Medical Education and Clinical Research) ; Zatarain-Barron, Zyanya Lucia (Instituto Nacional de Cancerología (Ciutat de Mèxic). Thoracic Oncology Unit) ; Corrales, Luis. (Department of Oncology. Centro de Investigación y Manejo del Cáncer, San José, Costa Rica) ; Martín, Claudio (Thoracic Oncology Unit. Alexander Fleming Institute) ; Barrón, Feliciano (Instituto Nacional de Cancerología (Ciutat de Mèxic). Thoracic Oncology Unit) ; Vargas, Carlos (Clinical and Translational Oncology Group. Clínica del Country, Bogotá) ; Carranza, Hernán (Clinical and Translational Oncology Group. Clínica del Country, Bogotá) ; Otero, Jorge (Clinical and Translational Oncology Group. Clínica del Country, Bogotá) ; Rodriguez, July (Molecular Oncology and Biology Systems Research Group. Universidad el Bosque) ; Sotelo, Carolina (Molecular Oncology and Biology Systems Research Group. Universidad el Bosque) ; Viola, Lucia (Fundación Neumológica Colombiana) ; Russo, Alessandro (Medical Oncology Unit. Azienda Ospedaliera Papardo) ; Rosell, Rafael (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Cardona Zorrilla, Andrés Felipe (Clínica del Country (Bogotà, Colòmbia))
PURPOSE: In the midst of a global pandemic, evidence suggests that similar to other severe respiratory viral infections, patients with cancer are at higher risk of becoming infected by COVID-19 and have a poorer prognosis. [...]
2020 - 10.1200/GO.20.00156
JCO global oncology, Vol. 6 (january 2020) , p. 752-760  
3.
12 p, 1.4 MB Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC / Chaib, Imane (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Karachaliou, Niki (Instituto Oncológico Dr. Rosell, Institut Universitari Quirón-Dexeus) ; Pilotto, Sara (Medical Oncology, Azienda Ospedaliera Universitaria Integrata, University of Verona) ; Codony-Servat, Jordi (Pangaea Biotech, Laboratory of Molecular Biology) ; Cai, Xueting (Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine) ; Li, Xuefei (Shangai Pulmonary Hospital, Tongji University School of Medicine, Shangai) ; Drozdowskyj, Ana (Pivotal, Madrid) ; Codony Servat, Carles (Pangaea Biotech, Laboratory of Molecular Biology) ; Yang, Jie (Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine) ; Hu, Chunping (Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine) ; Cardona Zorrilla, Andrés Felipe (Clinica del Country, Bogotá) ; Lopez Vivanco, Guillermo (Hospital Universitario de Cruces (Barakaldo, País Basc)) ; Vergnenegre, Alain (Service de Pathologie Respiratoire et d'Allergologie, CHU, Limoges France) ; Sanchez, Jose Miguel (Hospital Universitario de la Princesa (Madrid)) ; Provencio, Mariano (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Marinis, Filippo de (Hospital Universitario de Cruces (Barakaldo, País Basc)) ; Passaro, Antonio (Hospital Universitario de Cruces (Barakaldo, País Basc)) ; Carcereny, Enric (Service de Pathologie Respiratoire et d'Allergologie, CHU, Limoges France) ; Reguart, Noemi (Hospital Clínic i Provincial de Barcelona) ; Garcia Campelo, Charo (Hospital Universitario de la Princesa (Madrid)) ; Teixidó, Cristina (Pangaea Biotech, Laboratory of Molecular Biology) ; Sperduti, Isabella (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Rodriguez, Sonia (Pangaea Biotech, Laboratory of Molecular Biology) ; Lavazzi, Chiara (Hospital Universitario de Cruces (Barakaldo, País Basc)) ; Verlicchi, Alberto (Hospital Clínic i Provincial de Barcelona) ; Aguirre, Itziar de (Institut Germans Trias i Pujol) ; Queralt, C (Institut Germans Trias i Pujol) ; Wei, Jia (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Estrada-Tejedor, Roger (WVU Cancer Institute, West Virginia University, Morgantown, WV, USA) ; Puig de la Bellacasa, Raimon (WVU Cancer Institute, West Virginia University, Morgantown, WV, USA) ; Ramirez, Jose Luis (Institut Germans Trias i Pujol) ; Jacobson, Kirstine (WV Clinical and Translational Science Institute, Morgantown, WV, USA) ; Ditzel, Henrik J. (WV Clinical and Translational Science Institute, Morgantown, WV, USA) ; Santarpia, Mariacarmela (UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA) ; Viteri, Santiago (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Molina, Miguel Angel (Pangaea Biotech, Laboratory of Molecular Biology) ; Zhou, Caicun (Shangai Pulmonary Hospital, Tongji University School of Medicine, Shangai) ; Cao, Peng (Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China) ; Ma, Patrick C. (WVU Cancer Institute, West Virginia University, Morgantown, WV, USA) ; Bivona, Trever (UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA) ; Rosell, Rafael (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Background: The efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR-mutant non- small cell lung cancer (NSCLC) is limited by adaptive activation of cell survival signals. [...]
2017
Journal of the National Cancer Institute, Vol. 109 (september 2017) , p. 1-12  
4.
15 p, 1.1 MB Pemetrexed/Carboplatin/Bevacizumab followed by maintenance Pemetrexed/Bevacizumab in hispanic patients with non-squamous non-small cell lung cancer: outcomes according to Thymidylate Synthase Expression / Cardona Zorrilla, Andrés Felipe (Clínica del Country (Bogotà, Colòmbia)) ; Rojas, Leonardo (Fundación de Investigación Clínica y Molecular en Cáncer (Bogotà, Colòmbia)) ; Wills, Beatriz (Clínica del Country (Bogotà, Colòmbia)) ; Arrieta, Oscar (Instituto Nacional de Cancerología (Ciutat de Mèxic)) ; Carranza, Hernán (Clínica del Country (Bogotà, Colòmbia)) ; Vargas, Carlos (Clínica del Country (Bogotà, Colòmbia)) ; Otero, Jorge (Clínica del Country (Bogotà, Colòmbia)) ; Cuello, Mauricio (Universidad de la República (Montevideo, Uruguai)) ; Corrales, Luis (Hospital San Juan de Dios (San José, Costa Rica)) ; Martín, Claudio (Instituto Alexander Fleming (Buenos Aires, Argentina)) ; Ortiz, Carlos (Clínica del Country (Bogotà, Colòmbia)) ; Franco Cirera, Sandra (Clínica del Country (Bogotà, Colòmbia)) ; Rosell, Rafael (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Objective: To evaluate the efficacy and safety of pemetrexed, carboplatin and bevacizumab (PCB) followed by maintenance therapy with pemetrexed and bevacizumab (PB) in chemotherapy-naïve patients with stage IV non-squamous non-small cell lung cancer (NSCLC) through the influence of thymidylate synthase (TS) protein and mRNA expression on several outcomes. [...]
2016 - 10.1371/journal.pone.0154293
PloS one, Vol. 11 Núm. 5 (May 2016)  
5.
12 p, 942.4 KB BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer / Karachaliou, Niki (Hospital Universitari Quiron Dexeus (Barcelona, Catalunya)) ; Codony-Servat, Jordi (Pangaea Biotech (Barcelona, Catalunya)) ; Teixidó, Cristina (Pangaea Biotech (Barcelona, Catalunya)) ; Pilotto, Sara (University of Verona (Itàlia)) ; Drozdowskyj, Ana (Pivotal (Madrid)) ; Codony Servat, Carles (Pangaea Biotech (Barcelona, Catalunya)) ; Giménez-Capitán, Ana (Pangaea Biotech (Barcelona, Catalunya)) ; Molina-Vila, Miguel Ángel (Pangaea Biotech (Barcelona, Catalunya)) ; Bertrán-Alamillo, Jordi (Pangaea Biotech (Barcelona, Catalunya)) ; Gervais, Radj (Centre François Baclesse (Caen, França)) ; Massuti, Bartomeu (Hospital General Universitario de Alicante (Alacant, País Valencià)) ; Morán, Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Majem, Margarita (Institut d'Investigació Biomèdica Sant Pau) ; Felip, Enriqueta (Hospital Universitari Vall d'Hebron) ; Carcereny, Enric (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; García-Campelo, Rosario (Complejo Hospitalario Universitario de A Coruña) ; Viteri, Santiago (Hospital Universitari Quiron Dexeus (Barcelona, Catalunya)) ; González-Cao, María (Hospital Universitari Quiron Dexeus (Barcelona, Catalunya)) ; Morales-Espinosa, Daniela (Hospital Universitari Quiron Dexeus (Barcelona, Catalunya)) ; Verlicchi, Alberto (Ospedale Santa Maria delle Croci (Ravenna, Itàlia)) ; Crisetti, Elisabetta (Institute of Respiratory Diseases. University of Foggia (Itàlia)) ; Chaib, Imane (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Santarpia, Mariacarmela (Human Pathology Department. University of Messina (Itàlia)) ; Ramirez, Jose Luis (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Bosch-Barrera, J (Hospital Universitari de Girona Doctor Josep Trueta) ; Cardona Zorrilla, Andrés Felipe (Instituto de Oncología de Clínica del Country (Bogotá, Colòmbia)) ; De Marinis, Filippo (Istituto Europeo di Oncologia (Milà, Itàlia)) ; López-Vivanco, Guillermo (Hospital Universitario de Cruces (Barakaldo, País Basc)) ; Sánchez, José Miguel (Hospital Universitario de la Princesa (Madrid)) ; Vergnenegre, Alain (Hôpital du Cluzeau (Limoges, França)) ; Sánchez Hernández, José Javier (Universidad Autónoma de Nuevo León (Mèxic)) ; Sperduti, Isabella (Istituto Regina Elena Cancer Institute (Roma, Itàlia)) ; Bria, Emilio (University of Verona (Itàlia)) ; Rosell, Rafael (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Abstract. BIM is a proapoptotic protein that initiates apoptosis triggered by EGFR tyrosine kinase inhibitors (TKI). mTOR negatively regulates apoptosis and may influence response to EGFR TKI. We examined mRNA expression of BIM and MTOR in 57 patients with EGFR-mutant NSCLC from the EURTAC trial. [...]
2015 - 10.1038/srep17499
Scientific reports, Vol. 7 (December 2015)  

Research literature 1 records found  
1.
47 p, 878.2 KB Valor pronóstico de la densidad microvascular y de la expresión del VEGF, EGFR y HIF-1 en pacientes con cáncer de cérvix localmente avanzado tratados con quimioradiación / Cardona Zorrilla, Andrés Felipe ; Arellano Tolivar, Antonio ; Universitat Autònoma de Barcelona. Departament de Medicina ; Universitat Autònoma de Barcelona. Facultat de Medicina
2012  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.